港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

药明合联

62.800

-1.650-2.56%

成交量：645.25万

成交额：4.04亿

市值：790.02亿

市盈率：62.68

高：64.400

开：64.300

低：62.000

收：64.450

52周最高：85.500

52周最低：24.700

股本：12.58亿

香港流通股本：12.58亿

量比：1.91

换手率：0.51%

股息：- -

股息率：- -

每股收益(LYR):1.002

净资产收益率：19.76%

总资产收益率：9.04%

市净率：9.46

市盈率(LYR):62.68

市销率: 13.83

数据加载中...

总览公司新闻资讯公告

《大行》招银国际升药明合联(02268.HK)目标价至88元续吁“买入” 料盈利增长强劲

阿斯达克财经

【券商聚焦】中信证券：二次拐点已至，肿瘤基因检测处于爆发前夜

医药资本是个圈。。。

515亿温州富豪，28亿吞并苏州药企

21世纪经济报道

溢价超100%收购东曜药业，ADC外包龙头药明合联“抢时间”，能否缓解产能饥渴？

CXO龙头，宣布收购！

药融CDMO之家

药明合联迎娶东曜药业上演黑色幽默：31亿“彩礼”刚备好，自家股价“塌了房”

《大行》汇丰研究列出今年环球新兴市场最佳股份名单(表)

阿斯达克财经

【券商聚焦】招银国际维持药明合联(02268)买入评级指战略收购强化产能

《大行》野村：药明合联(02268.HK)2025年下半年业绩或逊预期

阿斯达克财经

药明合联(02268)股价下跌5.007%，现价港币$69.25

阿斯达克财经

31亿港元！CXO龙头收购一家CDMO公司

生物药大时代

一哥”3年砸100亿圈地，千亿市场正在“变天

药明合联“大并购”后，ADC CDMO的“整合竞速与齐放争鸣”

盖德化工网

2026年JPM大会诺华、阿斯利康、辉瑞等巨头超百亿美元交易频现，中国资产成最大赢家

药厂那点事儿

药明系再扩产能，溢价一倍收购上市药企

重磅消息接连来袭！业绩增长与并购并行，药明合联值得期待？

药明系落子收购东曜，ADC格局大变

ADC药物商业化拐点将到来：“卖水人”积极抢产能药明合联拟收购东曜药业

每日经济新闻

每日卖空追踪 | 药明合联 01月15日卖空量成交32.25万股，卖空比例为5.19%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02268/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":62.8,"timestamp":1769760484002,"preClose":64.45,"halted":0,"volume":6452454,"delay":0,"changeRate":-0.0256012412723042,"floatShares":1258000000,"shares":1258000000,"eps":1.0019577166242328,"marketStatus":"休市中","change":-1.65,"latestTime":"01-30 16:08:04","open":64.3,"high":64.4,"low":62,"amount":404425785,"amplitude":0.037238,"askPrice":62.8,"askSize":20000,"bidPrice":62.75,"bidSize":13000,"shortable":3,"etf":0,"ttmEps":1.1457398860998735,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":7,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":64.45,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":1.914750231084302,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1258000000,"roa":"9.04%","roe":"19.76%","lyrEps":1.001958,"volumeRatio":1.914750231084302,"shares":1258000000,"dividePrice":0,"high":64.4,"amplitude":0.037238,"preClose":64.45,"low":62,"week52Low":24.7,"pbRate":"9.46","psRate":"13.83","week52High":85.5,"institutionHeld":0,"latestPrice":62.8,"committee":-0.212121,"eps":1.0019577166242328,"divideRate":0,"volume":6452454,"delay":0,"ttmEps":1.1457398860998735,"open":64.3,"prevYearClose":60.75,"prevWeekClose":68.65,"prevMonthClose":60.75,"prevQuarterClose":60.75,"fiveDayClose":68.65,"twentyDayClose":61.35,"sixtyDayClose":70.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-18","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null},{"date":"2024-03-25","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.65,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.65,"analysts":20,"updateTime":1763740800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2026-01-30","current":54.811743,"percent":0.316176,"low":30.568632,"twenty":44.673253,"median":58.945496,"eighty":72.939295,"high":153.052589,"avg":64.806697,"sd":26.709985,"marketCap":79001941874},"quantilePoints":[{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191},{"date":"2025-04-11","current":35.581021,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":40380451549},{"date":"2025-04-17","current":33.597127,"twenty":0.4381,"median":49.700845,"eighty":72.980467,"marketCap":38220427395},{"date":"2025-04-25","current":39.226609,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44663120338},{"date":"2025-05-02","current":40.829264,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":46586700218},{"date":"2025-05-09","current":38.818219,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44603008467},{"date":"2025-05-16","current":39.608151,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":45882474676},{"date":"2025-05-23","current":38.196121,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44379117053},{"date":"2025-05-30","current":41.172242,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48047309655},{"date":"2025-06-06","current":42.866418,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":50152010328},{"date":"2025-06-13","current":46.041552,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":53888090995},{"date":"2025-06-20","current":41.240748,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48174509918},{"date":"2025-06-27","current":40.971553,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":47994081042},{"date":"2025-07-04","current":46.000985,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":53888090995},{"date":"2025-07-11","current":47.288014,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":55339986740},{"date":"2025-07-18","current":50.925924,"twenty":0.438098,"median":50.569275,"eighty":72.98104,"marketCap":59550637905},{"date":"2025-07-25","current":57.660678,"twenty":0.438098,"median":51.683826,"eighty":72.98104,"marketCap":67671179437},{"date":"2025-08-01","current":57.245588,"twenty":0.438098,"median":52.545804,"eighty":72.98104,"marketCap":66768897045},{"date":"2025-08-08","current":57.73965,"twenty":0.43811,"median":53.257543,"eighty":72.98104,"marketCap":67513611340},{"date":"2025-08-15","current":64.222783,"twenty":31.309336,"median":54.856958,"eighty":72.98104,"marketCap":74981664691},{"date":"2025-08-22","current":48.130228,"twenty":34.419063,"median":54.952855,"eighty":72.98104,"marketCap":69501077151},{"date":"2025-08-29","current":46.988345,"twenty":35.581021,"median":54.952855,"eighty":72.98104,"marketCap":68176099944},{"date":"2025-09-05","current":54.370406,"twenty":36.186031,"median":55.113399,"eighty":72.98104,"marketCap":78808670381},{"date":"2025-09-12","current":57.034752,"twenty":36.596757,"median":55.50873,"eighty":72.98104,"marketCap":82819396110},{"date":"2025-09-19","current":59.571504,"twenty":36.911418,"median":56.000464,"eighty":72.98104,"marketCap":86441593568},{"date":"2025-09-26","current":63.204858,"twenty":37.279949,"median":56.495601,"eighty":72.98104,"marketCap":91475834102},{"date":"2025-10-03","current":72.025865,"twenty":37.670679,"median":56.699916,"eighty":72.980467,"marketCap":104491187679},{"date":"2025-10-10","current":60.90024,"twenty":38.189538,"median":56.97042,"eighty":72.98104,"marketCap":88221995708},{"date":"2025-10-17","current":57.936353,"twenty":38.732076,"median":57.121577,"eighty":72.98104,"marketCap":83863080123},{"date":"2025-10-24","current":59.821834,"twenty":39.226609,"median":57.526112,"eighty":72.98104,"marketCap":86623810506},{"date":"2025-10-31","current":63.630196,"twenty":39.774995,"median":57.92353,"eighty":72.98104,"marketCap":92275860553},{"date":"2025-11-07","current":58.827143,"twenty":40.354886,"median":58.251953,"eighty":72.98104,"marketCap":85257233036},{"date":"2025-11-14","current":59.953959,"twenty":41.172242,"median":58.455089,"eighty":72.98104,"marketCap":87136525462},{"date":"2025-11-21","current":57.356344,"twenty":41.596291,"median":58.554061,"eighty":72.98104,"marketCap":83322340564},{"date":"2025-11-28","current":56.291024,"twenty":42.018405,"median":58.564991,"eighty":72.98104,"marketCap":82071768197},{"date":"2025-12-05","current":57.95451,"twenty":42.42494,"median":58.564991,"eighty":72.98104,"marketCap":84642388897},{"date":"2025-12-12","current":56.819112,"twenty":42.866418,"median":58.860686,"eighty":72.98104,"marketCap":83137635317},{"date":"2025-12-19","current":59.902097,"twenty":43.024716,"median":58.930609,"eighty":72.98104,"marketCap":87855221510},{"date":"2025-12-24","current":53.787136,"twenty":43.211711,"median":58.930609,"eighty":72.98104,"marketCap":79132453088},{"date":"2026-01-02","current":52.131715,"twenty":43.875774,"median":58.940897,"eighty":73.022778,"marketCap":76998826280},{"date":"2026-01-09","current":60.097118,"twenty":44.079539,"median":58.920321,"eighty":72.979321,"marketCap":88984788643},{"date":"2026-01-16","current":59.868148,"twenty":44.329264,"median":59.011667,"eighty":72.978748,"marketCap":88933823858},{"date":"2026-01-23","current":58.064858,"twenty":44.542103,"median":59.011667,"eighty":72.978748,"marketCap":86172293688},{"date":"2026-01-30","current":52.991062,"twenty":44.673253,"median":58.945496,"eighty":72.939295,"marketCap":79001941874}],"updateTime":1769864761525},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604390910","title":"《大行》招银国际升药明合联(02268.HK)目标价至88元续吁“买入” 料盈利增长强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2604390910","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604390910?lang=zh_cn&edition=fundamental","pubTime":"2026-01-19 10:25","pubTimestamp":1768789500,"startTime":"0","endTime":"0","summary":"招银国际研究报告指，药明合联发盈喜，料2025年收入将按年增长至少45%，净利润增长逾38%。2025年，公司新综合项目破纪录达70个，按年增长32%。为应对日益增长的客户需求，公司宣布以现金要约方式收购东曜药业至少60%权益，标志着公司进一步强化生产能力。该行将药明合联目标价由74元升至88元，维持“买入”评级，料2025至27年公司收入分别按年增长45.7%、36.6%及31.7%，经调整净利润增长34.9%、38.4%及32.9%；以上预测并未反映公司收购东曜药业的影响。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1496970/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1496970/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"gpt_icon":0},{"id":"2604903390","title":"【券商聚焦】中信证券：二次拐点已至，肿瘤基因检测处于爆发前夜","url":"https://stock-news.laohu8.com/highlight/detail?id=2604903390","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604903390?lang=zh_cn&edition=fundamental","pubTime":"2026-01-19 08:57","pubTimestamp":1768784264,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示，2025年我国药监局、医保局、卫健委三大监管部门出台多项涉及肿瘤基因检测相关的政策文件，从注册审批、物价、医保、临床应用等多个维度进行行业规范，该机构认为这一系列文件将助力肿瘤基因检测进入二次拐点，行业步入健康发展轨道。2026-2030年将是中国肿瘤基因检测行业的黄金发展期，政策、技术、市场三重利好叠加，该机构认为在这一趋势下，行业将经历新一轮整合，缺乏资质、技术和资金优势的中小企业被淘汰，头部企业有望通过\"合规产品+院内共建+海外拓展\"模式形成差异化竞争格局。当下该机构积极推荐：1）基因测序卖水人；2）肿瘤伴随诊断龙头。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973434","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196","LU1770034418.SGD","01789","LU2476274720.SGD","SG9999014674.SGD","09926","LU0640798160.USD","02268","03933","LU0348735423.USD","LU0588546209.SGD","LU0540923850.HKD","BK1588","LU2399975544.HKD","LU1794554557.SGD","LU0348784397.USD","LU1969619763.USD","BK1617","LU0348827113.USD","LU1115378108.SGD","LU1997244956.HKD","LU2495084118.USD","LU2488822045.USD","BK1516","BK1161","01530","BK0012","BK1141","LU1720050803.USD","LU0417516571.SGD","LU0417516738.SGD","BK1564","BK1191","LU1997245177.USD","IE00B543WZ88.USD","06160","02367","09688","600030","LU0348767384.USD","BK1207","LU1251922891.USD","06030","LU2328871848.SGD","LU2148510915.USD","BK1585","01099","BK0196","BK1147"],"gpt_icon":0},{"id":"2604134927","title":"医药资本是个圈。。。","url":"https://stock-news.laohu8.com/highlight/detail?id=2604134927","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604134927?lang=zh_cn&edition=fundamental","pubTime":"2026-01-18 08:18","pubTimestamp":1768695528,"startTime":"0","endTime":"0","summary":"生物医药资本圈，已形成一个由顶级产业集团与大型财务资本共同主导的、多维度交织的生态系统。一项统计显示：药明康德投资组合中的公司，有超过70%同时是其客户。即使被投企业最终失败，药明系仍能通过服务费回收部分投资。它们既是药明系资本的合作伙伴，也是系统内的功能模块。药明系的成功建立在生物医药行业持续融资、持续创新的基础上。当资本市场对biotech的热情降温，融资环境收紧时，这个循环的多个环节可能同时受到影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011808205097a23831&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011808205097a23831&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1515","BK1574","09939","SG9999014674.SGD","BK1141","02268","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2603991833","title":"515亿温州富豪，28亿吞并苏州药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991833","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603991833?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 21:42","pubTimestamp":1768570978,"startTime":"0","endTime":"0","summary":"温州医药首富李革，拿下一家同行。1月14日晚，他实控的药明合联，宣布将以现金要约方式，以31亿港元的估值，约合28亿人民币，控股东曜药业。李革的药明系较为慷慨，出价4港元/股，相较12月下旬2港元左右的股价，刚好溢价一倍，考虑部分购股权注销价为1.7665港元，其要约最高代价约27.9亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601163622167671.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601163622167671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0588546209.SGD","LU1242518857.USD","02269","02268","LU0516423174.USD","LU3063872942.SGD","LU1242518931.SGD","BK1610","BK4139","LU0856984785.SGD","LU0326950275.SGD","LU0417516902.SGD","LU1794554557.SGD","LU2488822045.USD","LU0307460666.USD","LU0516422440.USD","LU0823426308.USD","LU1720050803.USD","LU0348825331.USD","LU0140636845.USD","LU0417516738.SGD","CDMO","LU0456846285.SGD","LU0516423091.SGD","LU0456827905.SGD","BK1141","BK1521","LU0327786744.USD","SG9999002562.SGD","LU0823426480.USD","LU0359202008.SGD","LU0516422952.EUR","LU0572944931.SGD","LU0039217434.USD","LU2039709279.SGD","SG9999014674.SGD","LU0181495838.USD","IE00B0JY6N72.USD","LU0359201612.USD","LU0348735423.USD","BK1576","LU0979878070.USD","BK1589","SG9999002463.SGD","LU0516422366.SGD","LU0708995583.HKD","LU0051755006.USD","LU0052750758.USD","LU1688375341.USD","LU0043850808.USD"],"gpt_icon":0},{"id":"2603193967","title":"溢价超100%收购东曜药业，ADC外包龙头药明合联“抢时间”，能否缓解产能饥渴？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603193967","media":"时代财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603193967?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 18:46","pubTimestamp":1768560376,"startTime":"0","endTime":"0","summary":"溢价超100%收购东曜药业，ADC外包龙头药明合联“抢时间”，能否缓解产能饥渴？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601163622052082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADC","LU2488822045.USD","BK4080","BK1141","02268","BK4231","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603226998","title":"CXO龙头，宣布收购！","url":"https://stock-news.laohu8.com/highlight/detail?id=2603226998","media":"药融CDMO之家","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603226998?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 15:54","pubTimestamp":1768550079,"startTime":"0","endTime":"0","summary":"1月14日，药明合联发布2025财年盈喜公告，同时还披露其发起以现金要约方式收购东曜药业股份。同时宣布以4港元/股价格，收购东曜药业股份约7.73亿股，总估值约达30.91 亿港元。东曜药业早前已于2025年12月29日上午九时正起停止买卖，以待刊发关于现金要约的公告。根据东曜药业发布的2024年度业绩报告，公司全年营收超十亿，同比增长41%。CDMO/CMO业务收入人民币207,133千元，同比增长47%。2024年首次实现扭亏为盈，全年净利润达人民币34,757千元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011616444397a215e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011616444397a215e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","SG9999014674.SGD","LU2488822045.USD","BK1574","01875","BK1161"],"gpt_icon":0},{"id":"2603952146","title":"药明合联迎娶东曜药业上演黑色幽默：31亿“彩礼”刚备好，自家股价“塌了房”","url":"https://stock-news.laohu8.com/highlight/detail?id=2603952146","media":"星岛产研","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603952146?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 13:12","pubTimestamp":1768540332,"startTime":"0","endTime":"0","summary":"交易完成后，东曜药业将维持港股上市地位，成为药明合联及药明生物的附属公司并同步并表，短期内无重大业务及管理层调整计划。即便同日药明合联还发布了2025年业绩盈利预告，都未能挽回股价大跌的颓势。2025年上半年，东曜药业实现收入4.89亿元，净利润则为406万元。数据显示，2025年上半年，药明合联营业收入27.01亿元，同比增长62.2%；净利润为7.46亿元，增长52.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011614051697a20f4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011614051697a20f4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU3063872942.SGD","LU0823426480.USD","LU0516423091.SGD","LU0417516902.SGD","LU0516422440.USD","IE00B0JY6N72.USD","LU0181495838.USD","LU1688375341.USD","LU0823426308.USD","LU0856984785.SGD","LU0307460666.USD","LU1880383366.USD","LU0043850808.USD","LU0516422366.SGD","SG9999002463.SGD","LU0708995583.HKD","LU1794554557.SGD","LU0819121731.USD","LU1720050803.USD","LU0456846285.SGD","LU0052750758.USD","BK1576","LU0320764599.SGD","BK1610","LU0348825331.USD","LU0039217434.USD","BK1589","LU0516423174.USD","LU1242518931.SGD","SG9999002562.SGD","02269","SG9999014674.SGD","LU0417516738.SGD","LU0456827905.SGD","LU0327786744.USD","02268","LU0588546209.SGD","LU0572944931.SGD","BK1141","LU0979878070.USD","LU0359201612.USD","LU0359202008.SGD","LU0348735423.USD","LU0516422952.EUR","LU2039709279.SGD","LU1242518857.USD","BK1521","LU0140636845.USD","LU0051755006.USD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2603959467","title":"《大行》汇丰研究列出今年环球新兴市场最佳股份名单(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603959467","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603959467?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 11:53","pubTimestamp":1768535580,"startTime":"0","endTime":"0","summary":"汇丰环球研究近日发表报告，挑选出2026年环球新兴市场共26只最佳股份名单，在本港上市包括腾讯、地平线机器人及药明合联。) (美股为即时串流报价； OTC市场股票除外，资料延迟最少15分钟。)相关内容《大行》花旗列出H股首选股名单(表)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205150920018_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205150920018_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1496657/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1496657/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0228367735.SGD","LU1048596156.SGD","SG9999000459.SGD","LU0231483743.USD","LU1051768304.USD","LU0650527681.SGD","LU0918141887.USD","LU0577902611.USD","LU0173614495.USD","LU0985320562.USD","LU0868486357.SGD","LU0264606111.USD","LU0672654166.SGD","LU1328277881.USD","SG9999014914.USD","LU2289578879.USD","LU0469268626.HKD","LU0541502299.USD","LU2152927971.USD","LU1785774172.SGD","LU0348827113.USD","LU1439102457.SGD","LU0819121731.USD","LU0784639295.USD","LU0620787316.HKD","LU0708995153.HKD","LU0163747925.USD","LU0572940350.SGD","LU0501845795.SGD","SG9999004220.SGD","LU2097828474.EUR","LU1044876610.USD","TCEHY","LU2097828631.EUR","LU0823426308.USD","LU2039709279.SGD","LU0572944931.SGD","LU0348816934.USD","LU0683595622.HKD","LU0577902371.SGD","LU1997244956.HKD","LU0106252389.USD","LU0067412154.USD","LU2399975544.HKD","LU0328353924.USD","BK1586","LU2237443382.USD","LU2125910849.SGD","LU1196710351.USD","LU0648948544.HKD","LU0370786039.SGD","BK1615","09660","HK0000352291.HKD","IE00B031J352.USD","LU0047713382.USD","LU0210526637.USD","LU0293314216.USD","LU2488822045.USD","LU0865486749.SGD","LU0577902454.USD","LU1224444064.USD","LU0823413660.USD","LU0329678170.USD","LU0259732245.USD","LU0577902298.EUR","LU2462611646.USD","LU0531970944.HKD","BK0070","LU0211331839.USD","LU1226287792.SGD","LU2008162690.USD","LU0642271901.SGD","BK1591","BK0167","LU0449509016.USD","LU2362540622.SGD","LU1725190679.HKD","SG9999018865.SGD","LU0886674414.USD","BK1609","LU0862451837.USD","SG9999003461.SGD","LU0972618739.USD","LU0048597586.USD","LU0082770016.USD","LU2247934214.USD","LU2087589342.USD","LU2237443895.HKD","SG9999006514.SGD","IE00BQXX3F31.USD","LU1105468828.SGD","LU2242644610.SGD","IE0008368411.USD","LU1282649141.HKD","LU1023057109.AUD","IE00B031HW06.USD","LU1235295612.USD","LU1642822792.SGD","LU0072913022.USD","LU0164939612.USD","LU2279701549.SGD","LU1366334578.USD","LU1102505762.USD","LU1688375341.USD","IE00BPRC5H50.USD","BK1517","LU1282648689.USD","IE0008369823.USD","LU1794554557.SGD","HK0000352382.USD","LU0048388663.USD","LU1917777945.USD","LU0320764599.SGD","300308","LU0244354667.USD","LU2023250504.SGD","IE0032431581.USD","LU0823413587.USD","LU1064131003.USD","02268","LU0791590937.USD","LU2498475776.HKD","IE00B97KM107.HKD","LU2045819591.USD","LU1328615791.USD","LU2778985437.USD","LU0633140727.USD","SG9999000327.SGD","HK0000320223.HKD","LU1242518857.USD","LU0235996351.USD","SG9999018857.SGD","SG9999001226.SGD","LU0165289439.USD","IE0031814852.USD","LU0737861699.HKD","LU1769817096.USD","TCHmain","SG9999015978.USD","LU1048484197.HKD","SG9999014906.USD","LU0196878994.USD","LU0737861772.HKD","IE00B29SXG58.USD","LU0708995583.HKD","LU0828237940.HKD","LU0329678337.USD","IE0003795394.USD","IE00B3M56506.USD","LU0417516738.SGD","LU1769817179.HKD","BK1521","LU0228659784.USD","LU0396098781.USD","LU0516422366.SGD","LU1629966141.USD","LU0211977185.USD","LU0797268264.HKD","LU0593848301.USD","LU0082770016.SGD","IE00B8HQ1Z84.USD","LU0052750758.USD","LU0509642566.USD","LU2226246903.HKD","IE00B0169N27.USD","LU0516422440.USD","SG9999017495.SGD","LU0348788117.USD","IE00B067MR52.USD","LU0061477393.USD","BK1610","LU0054237671.USD","LU1733274473.HKD","LU0214875030.USD","LU1807302812.USD","LU0456846285.SGD","SG9999001689.USD","LU0054450605.USD","LU0823426480.USD","BK1109","LU0164872284.USD","LU0880133367.SGD","LU2237443549.SGD","SG9999013353.USD","LU0588545904.SGD","LU1102505929.USD","LU0543330566.HKD","LU2097828805.USD","LU0873338254.USD","LU0456842615.SGD","LU1808992512.USD","LU2125910500.SGD","LU0577902538.SGD","09961","LU1008478684.HKD","LU0307460666.USD","IE00BZ08YT58.USD","LU0882747503.HKD","LU1046422090.SGD","LU0043850808.USD","SG9999002562.SGD","SG9999015945.SGD","LU1282651048.USD","LU0608807946.USD","LU1770036033.HKD","LU1719994722.HKD","LU1718418525.SGD","LU0251144936.SGD","LU0327786744.USD","LU0414403682.SGD","LU0463099449.HKD","LU0117844026.USD","SG9999014898.SGD","BK0028","LU0516423174.USD","SGXZ31699556.SGD","LU0502904849.HKD","LU0516423091.SGD","IE0003851619.USD","TCOM","LU0143863198.USD","IE0003895053.USD","LU2362541513.USD","BK1141","LU1770034418.SGD","LU1366334651.USD","LU2495084118.USD","LU0029874905.USD","IE0009570106.USD","LU1152091754.HKD","LU0359201612.USD","LU0455707207.USD","LU0651947912.USD","LU0499858438.USD","IE00B0169L03.USD","LU1152091168.USD","LU2580892789.USD","SG9999014674.SGD","SGXZ81514606.USD","LU0823039010.USD","IE0034224299.USD","LU1323998911.USD","LU0143863784.USD","LU0791591158.USD","BK1589","LU0106959298.USD","LU0611395673.USD","IE00BGV7N243.SGD","LU1226288097.SGD","IE00B031HY20.USD","LU0594300419.USD","LU0203345920.USD","BK1531","LU0348783662.USD","LU0320764755.SGD","LU0456827905.SGD","LU2257852520.SGD","LU0871576103.HKD","LU0898667661.SGD","SG9999015952.SGD","LU0348735423.USD","LU1960683339.HKD","LU1655091459.SGD","00700","LU0878004406.USD","LU2237443622.USD","LU1880383440.USD","LU1303224171.USD","LU1196710195.USD","LU1251922891.USD","LU0169518387.USD","IE0032834883.USD","LU0607220059.USD","LU1781817850.SGD","LU1515016050.SGD","LU0315178854.USD","BK1618","LU1831875114.USD","LU2237443978.SGD","LU0856984785.SGD","MELI","LU0786609619.USD","LU1282649810.SGD","LU0070217475.USD","BK0214","LU0979878070.USD","LU0117841782.USD","LU0878005551.USD","LU0128522744.USD","LU1974910355.USD","LU0096374516.USD","LU1868838027.USD","HK0000320264.USD","LU0821914370.USD","LU1504937902.USD","LU1226287875.USD","LU0345769631.USD","LU0348783233.USD","LU1981816686.USD","IE00BZ08YS42.EUR","LU0823038988.USD","LU2476274308.USD","LU0823397103.USD","LU0359202008.SGD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU0828237510.HKD","LU0608807433.USD","LU2251237488.HKD","LU0072462343.USD","SGXZ81163826.USD","HK0000306685.HKD","LU0918141705.HKD","LU0345776255.USD","LU2265009873.SGD","LU0164865239.USD","BK0077","LU0254981946.USD","LU0029875118.USD","LU1883866441.USD","LU2476274720.SGD","SG9999001051.SGD","LU0188438112.USD","IE00BZ08YR35.GBP","LU1282651121.HKD","LU0543330483.HKD","LU1481107354.HKD","LU2097828557.USD","LU0051755006.USD","SG9999001903.USD","LU2237443465.HKD","LU0561508036.HKD","LU0107464264.USD","LU0345775950.USD","LU1051769294.HKD","LU1226288170.HKD","LU1316542783.SGD","LU0823397285.USD","LU0140636845.USD","LU0039217434.USD","LU0417516571.SGD","LU1868837565.USD","LU2293587155.HKD","LU0149534421.HKD","LU0572939691.SGD","SGXZ51526630.SGD","SG9999001093.SGD","BK1516","LU0700851271.USD","IE00B8L5B284.USD","LU1720050803.USD","LU0441854154.USD","LU0175139822.USD","LU0594300179.USD","SG9999002828.SGD","IE00B0JY6N72.USD","LU1044875133.USD","SGXZ99366536.SGD","LU0488056044.USD","LU0348723411.USD","LU1951186391.HKD","LU0320764243.SGD","LU0192582467.USD","LU1868837722.USD","SGXZ49509284.SGD","LU0831103253.SGD","BK1095","LU0210533765.USD","LU1804176565.USD","BK1526","IE00BF5LJ272.USD","SG9999001069.SGD","LU2362541273.HKD","SG9999006597.SGD","LU0164880469.USD","LU0862451753.SGD","SG9999015986.USD","LU1224709979.USD","LU0128522157.USD","LU0106259558.USD","LU2133065610.SGD","LU0289960550.SGD","LU0828238088.HKD","LU0499858602.USD","LU0675040207.SGD","LU1044874839.SGD","LU2251237306.USD","LU0326950275.SGD","LU1439103000.SGD","LU0588545490.SGD","LU1655091616.SGD","LU0011963245.USD","LU0348784397.USD","LU1880383366.USD","LU0348814723.USD","LU0819123356.HKD","GB00BDT5M118.USD","LU0417516902.SGD","LU1814569148.SGD","LU1956131251.USD","LU1226287529.USD","LU1196710864.SGD","LU0738912210.USD","LU1997245094.SGD","LU1242518931.SGD","LU1188198961.HKD","HK0000306701.USD","LU1568876335.HKD","LU1226288253.USD","LU2051468812.USD","LU0080751232.USD","LU0048580855.USD","LU0314109678.HKD","HK0000914660.USD","LU0589944569.HKD","LU0229945570.USD","IE00BQXX3D17.EUR","LU0049853897.USD","LU0384037296.USD","LU1211504680.USD","LU2177674079.SGD","IE0008368742.USD","LU2580892862.HKD","LU0269904917.USD","LU1961090484.USD","LU0634319403.HKD","LU1997245177.USD","LU1568876251.USD","LU2449936058.SGD","IE0001KFT4U8.USD","IE00BYTNYN87.SGD","LU0210527791.USD","LU1580142542.USD","LU0348805143.USD","HK0000914686.HKD","SG9999002463.SGD","LU0348825331.USD","SG9999001846.SGD","LU0540923850.HKD","LU1733274390.USD","LU0049112450.USD","LU0149721374.USD","LU1064130708.USD","LU2097828714.EUR","LU0132412106.USD","LU0261947096.USD","IE00B543WZ88.USD","LU0531971595.HKD","LU0359201885.HKD","LU0326948709.USD","LU1810669033.SGD","LU1675838814.USD","LU1734074674.USD","SGXZ90724238.SGD","LU0084288322.USD","BK1502","LU0823041008.USD","SG9999007991.SGD","IE00BYQNZ168.SGD","LU0516422952.EUR","LU0823040885.USD","LU0633140560.USD","LU2148510915.USD","LU0651946864.USD","LU0431992006.USD","LU2317271919.USD","LU0181495838.USD","HTCD.SI","LU0605514214.HKD","LU1282649067.USD","BK1608","LU0588545730.USD","LU1813983027.USD","LU2106854487.HKD","SG9999014880.SGD","LU0261950983.USD","LU0127658192.USD","LU1048588211.SGD","IE00BQXX3C00.GBP","LU0890818403.SGD","SG9999011746.SGD","LU0203347892.USD","LU0449515922.USD","LU0588546209.SGD","LU3063872942.SGD","SG9999000418.SGD","LU0345769128.USD","LU0287142896.SGD","LU0541501648.USD","IE00B12V2V27.USD"],"gpt_icon":1},{"id":"2603562159","title":"【券商聚焦】招银国际维持药明合联(02268)买入评级 指战略收购强化产能","url":"https://stock-news.laohu8.com/highlight/detail?id=2603562159","media":"金吾财讯","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603562159?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 11:36","pubTimestamp":1768534595,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，药明合联 发布2025年业绩预增公告，预计收入同比增长至少45%，净利润将同比增长至少38%，扣除利息收入和费用前经调整净利润同比增长超过45%，如再剔除汇率影响，此利润将同比增长超65%。该机构指，药明合联计划通过现金要约的形式收购东曜药业至少60%的股权，收购价为每股4港元，较东曜药业12月24日的收盘价溢价99%。维持买入评级，上调目标价至88港元，以反映公司进一步强化的全球竞争力以及积极的需求展望。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973376","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2603955447","title":"《大行》野村：药明合联(02268.HK)2025年下半年业绩或逊预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2603955447","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603955447?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 10:46","pubTimestamp":1768531560,"startTime":"0","endTime":"0","summary":"野村发表报告，预计药明合联2025年下半年业绩或逊预期。公司发盈喜，预计2025财年收入、毛利、经调整净利润及股东应占净利润按年增长分别超过45%、70%、45%及38%。该行予其“买入”评级，目标价82.72元。沽空资料截至 2026-01-15 16:25。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104105862_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104105862_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1496620/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1496620/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","SG9999014674.SGD","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2603953788","title":"药明合联(02268)股价下跌5.007%，现价港币$69.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2603953788","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603953788?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 10:25","pubTimestamp":1768530300,"startTime":"0","endTime":"0","summary":"[下跌股]药明合联(02268) 股价在上午10:25比前收市价下跌5.007%，现股价为港币$69.25。至目前为止，今日最高价为$73.35，而最低价为$69.25。总成交量为252.77万股，总成交金额为港币$1.79亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260116871/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260116871/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02268","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603951020","title":"31亿港元！CXO龙头收购一家CDMO公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2603951020","media":"生物药大时代","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603951020?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 10:20","pubTimestamp":1768530005,"startTime":"0","endTime":"0","summary":"1月14日，药明合联发布2025财年盈喜公告，同时还披露其发起以现金要约方式收购东曜药业股份。同时宣布以4港元/股价格，收购东曜药业股份约7.73亿股，总估值约达30.91 亿港元。东曜药业早前已于2025年12月29日上午九时正起停止买卖，以待刊发关于现金要约的公告。根据东曜药业发布的2024年度业绩报告，公司全年营收超十亿，同比增长41%。CDMO/CMO业务收入人民币207,133千元，同比增长47%。2024年首次实现扭亏为盈，全年净利润达人民币34,757千元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116102143a4c9e107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116102143a4c9e107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"gpt_icon":0},{"id":"2603954830","title":"一哥”3年砸100亿圈地，千亿市场正在“变天","url":"https://stock-news.laohu8.com/highlight/detail?id=2603954830","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603954830?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 09:49","pubTimestamp":1768528160,"startTime":"0","endTime":"0","summary":"这一收购价较东曜药业2025年12月22日收盘价溢价99%，较过去30个交易日平均收盘价更是溢价114.67%。其二，强化市场地位。从“拼价格”到“拼体系”中国的ADC CDMO，正在“变身”。皓元医药2025年前三季度前端业务营收14.5亿元，同比增长31%，后端业务营收6亿元，同比增长16.9%。其承接的XDC项目超70个，截至2025年6月，在22家ADC出海的国内公司中，服务了95%以上出","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116095150a4c9c462&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116095150a4c9c462&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1191","BK1141","01875","LU2488822045.USD","06821","02268"],"gpt_icon":0},{"id":"2603954866","title":"药明合联“大并购”后，ADC CDMO的“整合竞速与齐放争鸣”","url":"https://stock-news.laohu8.com/highlight/detail?id=2603954866","media":"盖德化工网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603954866?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 08:00","pubTimestamp":1768521641,"startTime":"0","endTime":"0","summary":"并购会催动产业“整合竞速”，但不构成市场担心的“一家独大”，国产ADC CDMO依然在“齐放争鸣”的路上昂扬行进。收购完成后，药明合联计划维持东曜药业上市地位，这也表明其战略意图并非私有化套利，而是战略性控股整合，保留东曜药业作为独立运营实体，继续服务现有客户。目前，国内ADC CDMO产业呈现“齐放争鸣”的竞争格局态势，详见盖德视界此前报道：产能狂飙项目突围：中国 ADC CDMO 头部玩家全景透视。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116080713a7205a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116080713a7205a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603937939","title":"2026年JPM大会诺华、阿斯利康、辉瑞等巨头超百亿美元交易频现，中国资产成最大赢家","url":"https://stock-news.laohu8.com/highlight/detail?id=2603937939","media":"药厂那点事儿","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603937939?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 07:05","pubTimestamp":1768518317,"startTime":"0","endTime":"0","summary":"巨头交易频现，中国资产备受青睐。诺华公司周二下午宣布了一项针对中国生物技术公司泽璟生物的许可交易。再生元计划在2026年公布该药用于肥胖治疗的中国3期临床试验结果，并启动全球3期临床开发计划。截至2025年第三季度，19家大型制药公司现金储备总额超过1700亿美元，2025年前三季度产生了约1400亿美元的自由现金流，为大规模并购交易提供了充足的资金支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116070908a4c93942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116070908a4c93942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","02269","ZLAB","BK1574","BK1161","06855","06978","BK1191","01530","02615","01477","02268","AAPG","09688"],"gpt_icon":0},{"id":"2603982881","title":"药明系再扩产能，溢价一倍收购上市药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2603982881","media":"健识局","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603982881?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 20:30","pubTimestamp":1768480210,"startTime":"0","endTime":"0","summary":"1月14日晚，药明系几家上市公司抛出一份联合公告：药明合联以现金每股4港元的价格，向东曜药业提出全面收购要约。消息发布后，1月15日，东曜药业股价大幅拉升最高77%。另外，截至去年上半年，东曜药业新增14个ADC项目，累计至169个项目。当然，药明合联已经未雨绸缪，表示收购完成后，继续维持东曜药业的上市地位。但同时，也将持续检讨东曜药业的营运，保留对公司业务和营运作出认为必要或适当的任何变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115203521a71eaac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115203521a71eaac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1141","SG9999014674.SGD","01875","02268"],"gpt_icon":0},{"id":"2603098834","title":"重磅消息接连来袭！业绩增长与并购并行，药明合联值得期待？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603098834","media":"港股解码","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603098834?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 19:03","pubTimestamp":1768475036,"startTime":"0","endTime":"0","summary":"值得一提的是，亮眼的业绩也为药明合联赢得了市场认可。同日披露重磅消息，溢价收购东曜药业除了亮眼的业绩预告外，药明合联还在同日披露了一则重磅收购消息。2025年半年报显示，期内，东曜药业新增的16个项目，其中14个为ADC，业务结构与药明合联核心赛道高度匹配。在披露预期向好的业绩及并购消息后，1月15日，药明合联的股价遭遇了跳空下跌，截至收盘跌3.76%，打破了近期连续上涨的势头，不过成交量并未放大，尚属于正常调整范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115190719a71e5bfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115190719a71e5bfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","02268","BK1141","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603988341","title":"药明系落子收购东曜，ADC格局大变","url":"https://stock-news.laohu8.com/highlight/detail?id=2603988341","media":"新浪财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603988341?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 18:01","pubTimestamp":1768471270,"startTime":"0","endTime":"0","summary":"据悉，东曜药业股份自2025年12月29日起暂停买卖，已于1月15日上午九时恢复交易。药明合联表示，完成后将维持东曜药业上市地位，短期内无重大业务、管理层及员工变动计划，长期将根据实际情况优化运营以提升价值。此次收购发布的同时，药明合联发布2025年盈喜公告，营收同比增长超45%，经调整净利润增幅超45%。在此背景下，药明合联收购东曜药业，这步战略布局不仅是一次简单的规模扩张，也为应对未来更激烈的竞争布下关键一子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115180414a71e200d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115180414a71e200d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2603670936","title":"ADC药物商业化拐点将到来：“卖水人”积极抢产能 药明合联拟收购东曜药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2603670936","media":"每日经济新闻","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603670936?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 16:45","pubTimestamp":1768466743,"startTime":"0","endTime":"0","summary":"随着ADC药物（抗体偶联药物）临床管线持续扩容，商业化拐点已至，产能缺口进一步凸显。1月14日，行业龙头药明合联宣布，拟以4港元/股的价格收购东曜药业股份约7.73亿股。后者是国内最早一批研发抗体偶联药物的企业，近年来转型为CDMO（合同定制研发生产）赛道，其中的ADCCDMO是其区别于其他同行业企业的特殊之处。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601153620443970.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601153620443970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","BK4231","SG9999014674.SGD","02268","ADC","BK1141","LU2488822045.USD"],"gpt_icon":0},{"id":"2603414670","title":"每日卖空追踪 | 药明合联 01月15日卖空量成交32.25万股，卖空比例为5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603414670","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603414670?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 16:30","pubTimestamp":1768465829,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月15日，跌3.76%，卖空量成交32.25万股，较上一交易日减少49.37%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164042a4c6d327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164042a4c6d327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}